Paul K. Wotton

2009

In 2009, Paul K. Wotton earned a total compensation of $636K as Chief Executive Officer at Antares Pharma, a 1% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$140,000
Option Awards$91,238
Salary$337,000
Stock Awards$59,500
Other$8,250
Total$635,988

Wotton received $337K in salary, accounting for 53% of the total pay in 2009.

Wotton also received $140K in non-equity incentive plan, $91.2K in option awards, $59.5K in stock awards and $8.3K in other compensation.

Rankings

In 2009, Paul K. Wotton's compensation ranked 6,015th out of 9,885 executives tracked by ExecPay. In other words, Wotton earned more than 39.2% of executives.

ClassificationRankingPercentile
All
6,015
out of 9,885
39th
Division
Manufacturing
2,176
out of 3,690
41st
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
326
out of 607
46th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
170
out of 331
49th
Industry
Surgical and Medical Instruments and Apparatus
112
out of 217
48th
Source: SEC filing on April 13, 2012.

Wotton's colleagues

We found three more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2009.

2009

Dario Carrara

Antares Pharma

Managing Director, Pharmaceutical Group

2009

Robert Apple

Antares Pharma

Chief Financial Officer

2009

Peter Sadowski

Antares Pharma

Chief Technology Officer

You may also like